Brough Chris, Miller Dave A, Keen Justin M, Kucera Shawn A, Lubda Dieter, Williams Robert O
Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, 1 University Station, Campus Mail Code A1902, Austin, Texas, 78712, USA.
DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 3, Georgetown, Texas, 78626, USA.
AAPS PharmSciTech. 2016 Feb;17(1):167-79. doi: 10.1208/s12249-015-0458-y. Epub 2015 Dec 4.
Polyvinyl alcohol (PVAL) has not been investigated in a binary formulation as a concentration-enhancing polymer owing to its high melting point/high viscosity and poor organic solubility. Due to the unique attributes of the KinetiSol® dispersing (KSD) technology, PVAL has been enabled for this application and it is the aim of this paper to investigate various grades for improvement of the solubility and bioavailability of poorly water soluble active pharmaceutical ingredients. Solid amorphous dispersions were created with the model drug, itraconazole (ITZ), at a selected drug loading of 20%. Polymer grades were chosen with variation in molecular weight and degree of hydroxylation to determine the effects on performance. Differential scanning calorimetry, powder X-ray diffraction, polarized light microscopy, size exclusion chromatography, and dissolution testing were used to characterize the amorphous dispersions. An in vivo pharmacokinetic study in rats was also conducted to compare the selected formulation to current market formulations of ITZ. The 4-88 grade of PVAL was determined to be effective at enhancing solubility and bioavailability of itraconazole.
由于聚乙烯醇(PVAL)熔点高、粘度大且有机溶解性差,尚未作为浓度增强聚合物在二元制剂中进行研究。由于KinetiSol®分散(KSD)技术的独特特性,PVAL已适用于此应用,本文旨在研究不同等级的PVAL,以改善难溶性活性药物成分的溶解度和生物利用度。以模型药物伊曲康唑(ITZ)制备了固体无定形分散体,选定的药物载量为20%。选择了分子量和羟基化程度不同的聚合物等级,以确定其对性能的影响。采用差示扫描量热法、粉末X射线衍射法、偏光显微镜法、尺寸排阻色谱法和溶出度试验对无定形分散体进行表征。还进行了大鼠体内药代动力学研究,以将选定的制剂与ITZ的市售制剂进行比较。已确定PVAL的4-88等级在提高伊曲康唑的溶解度和生物利用度方面有效。